ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,976.97
      -1.13%
      US Tech 100
      21,079.20
      -1.25%
      Dow Jones
      42,197.79
      -1.79%
      Brent Oil
      76.565
      3.73%
      Bitcoin
      104,813.90
      -0.62%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      06/09/202510:03AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/06/20255:40PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/03/20254:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/03/20254:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/03/20254:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/03/20254:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/03/20254:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/03/20254:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/29/20258:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/19/20258:00AMGlobeNewswire Inc.SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of CardiologyNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/14/20257:08AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/13/20255:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/13/20255:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/13/20255:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/13/20255:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/13/20254:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/13/20254:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business UpdatesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/06/20254:30PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/06/20258:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/22/20257:11AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/22/20257:09AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/22/20257:07AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/02/20258:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/28/20257:59AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/28/20257:30AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/25/20254:05PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/07/20254:02PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/07/20258:30AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/06/20254:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/06/20254:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdatesNASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX